Generated: December 11, 2017
DrugPatentWatch Database Preview
Nortriptyline hydrochloride - Generic Drug Details
« Back to Dashboard
What are the generic sources for nortriptyline hydrochloride and what is the scope of nortriptyline hydrochloride patent protection?
is the generic ingredient in four branded drugs marketed by Lilly, Aurolife Pharma Llc, Idt Australia Ltd, Mayne Pharma, Mylan, Taro Pharm, Teva, Mallinckrodt Llc, Ranbaxy, Pharm Assoc, Taro, and Mallinckrodt Inc, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.
There are eleven drug master file entries for nortriptyline hydrochloride. Thirty-four suppliers are listed for this compound.
Summary for nortriptyline hydrochloride
Pharmacology for nortriptyline hydrochloride
Medical Subject Heading (MeSH) Categories for nortriptyline hydrochloride
|Taro Pharm||NORTRIPTYLINE HYDROCHLORIDE||nortriptyline hydrochloride||CAPSULE;ORAL||075520-003||May 8, 2000||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Ranbaxy||AVENTYL ||nortriptyline hydrochloride||SOLUTION;ORAL||014685-001||Approved Prior to Jan 1, 1982||DISCN||Yes||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Teva||NORTRIPTYLINE HYDROCHLORIDE||nortriptyline hydrochloride||CAPSULE;ORAL||074132-004||Mar 27, 1995||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Mylan||NORTRIPTYLINE HYDROCHLORIDE||nortriptyline hydrochloride||CAPSULE;ORAL||074234-003||Jul 26, 1993||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Teva||NORTRIPTYLINE HYDROCHLORIDE||nortriptyline hydrochloride||CAPSULE;ORAL||074132-002||Mar 27, 1995||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Lilly||AVENTYL HYDROCHLORIDE||nortriptyline hydrochloride||CAPSULE;ORAL||014684-001||Approved Prior to Jan 1, 1982||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Teva||NORTRIPTYLINE HYDROCHLORIDE||nortriptyline hydrochloride||CAPSULE;ORAL||074132-003||Mar 27, 1995||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Idt Australia Ltd||NORTRIPTYLINE HYDROCHLORIDE||nortriptyline hydrochloride||CAPSULE;ORAL||074054-004||Dec 31, 1992||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Teva||NORTRIPTYLINE HYDROCHLORIDE||nortriptyline hydrochloride||CAPSULE;ORAL||073667-002||Apr 11, 1996||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Mallinckrodt Llc||PAMELOR||nortriptyline hydrochloride||CAPSULE;ORAL||018013-001||Approved Prior to Jan 1, 1982||AB||RX||Yes||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Expired Orange Book Patents for Generic Ingredient: nortriptyline hydrochloride
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.